Investor Presentaiton

Investor Presentation First six months of 2018 The GLP-1 segment accounts for around 1% of the total diabetes care market value in Region China Slide 71 GLP-1 value in DKK China GLP-1 market VictozaⓇ exenatide Share of total diabetes care GLP-1 value VictozaⓇ value market share in China VictozaⓇ exenatide market share billion 0.20 market 100% 2.0% CAGR value¹: 29.3% 0.15 80% 78% 1.5% 60% 0.10 - 1.0% 40% 0.05 + 0.5% 20% 21% 0.00 May 2013 0.0% 0% May 2018 May 2013 May 2018 1 CAGR for 5-year period Source: IQVIA monthly MAT May, 2018 value figures (DKK) changing diabetes Source: IQVIA monthly MAT May, 2018 value figures (DKK), market share does not add up to 100% due to rounding novo nordisk

View entire presentation